Watchlist Price Alert

Niagen Bioscience Inc (NAGE)

NASDAQ: NAGE · Real-Time Price · USD

13.91

-0.23 (-1.63%)

At close: Jun 17, 2025, 2:28 PM

Niagen Bioscience Inc Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	44.51M	27.17M	20.29M	28.02M	16.5M	18.61M	22.42M	45.39M	1.64M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	20.32K
Other Long-Term Assets	368K	383K	497K	723K	625K	762K	566K	1.02M	1.73M
Receivables	7.77M	5.23M	8.48M	5.23M	2.69M	2.17M	4.42M	5.34M	5.85M
Inventory	9.19M	14.53M	14.68M	13.6M	11.68M	11.54M	8.25M	5.8M	7.91M
Other Current Assets	1.05M	2.6M	3.12M	200K	200K	200K	877K	n/a	18.32K
Total Current Assets	64.1M	49.53M	46.57M	48.91M	32.22M	33.52M	36.53M	57.18M	15.74M
Property-Plant & Equipment	3.45M	4.54M	6.32M	7.36M	4.43M	4.66M	3.58M	2.87M	1.78M
Goodwill & Intangibles	359K	510K	671K	857K	1.08M	1.31M	1.55M	1.65M	486K
Total Long-Term Assets	4.18M	5.43M	7.49M	8.94M	6.14M	6.73M	5.7M	5.54M	4.01M
Total Assets	68.28M	54.96M	54.06M	57.84M	38.36M	40.25M	42.23M	62.72M	19.75M
Account Payables	8.53M	10.23M	9.68M	10.42M	9.45M	9.63M	9.55M	3.72M	5.98M
Deferred Revenue	n/a	195K	157K	161K	278K	169K	275K	314K	389.01K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	611K	n/a	n/a	n/a	n/a	n/a	n/a	114K	76.22K
Total Current Liabilities	17.95M	20.62M	17.87M	17.61M	16.48M	15.06M	14.44M	8.09M	8.87M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	477K	492K	564.97K
Total Long-Term Liabilities	4.24M	5.89M	7.52M	8.5M	5.46M	4.74M	614K	802K	908.56K
Total Liabilities	22.18M	26.51M	25.39M	26.11M	21.93M	19.8M	15.05M	8.89M	9.78M
Total Debt	2.65M	3.28M	4.26M	4.7M	1.64M	1.72M	310K	506K	599.05K
Common Stock	77K	75K	74K	68K	62K	60K	55K	55K	37.55K
Retained Earnings	-181.91M	-190.46M	-185.49M	-168.95M	-141.82M	-121.9M	-89.75M	-56.6M	-45.22M
Comprehensive Income	-4K	-4K	-3K	-2K	-3K	n/a	n/a	n/a	n/a
Shareholders Equity	46.09M	28.46M	28.67M	31.73M	16.42M	20.45M	27.18M	53.83M	9.97M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	20.32K